{"id":"W2889677173","doi":"10.1200/jco.2018.36.15_suppl.9537","title":"Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Avelumab; Medicine; Merkel cell carcinoma; Expanded access; Internal medicine; Progressive disease; Merkel cell polyomavirus; Clinical trial; Oncology; Carcinoma; Chemotherapy; Nivolumab; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002792621,0.0002281695,0.001645955,0.00007302499,0.00004977697,0.00001462185,0.0002445876,0.0002428387,0.0007343286],"category_scores_gemma":[0.0003447403,0.0001271182,0.0004561032,0.000188026,0.0006052856,0.0001674727,0.00005548026,0.0002585796,0.00001438608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002217214,"about_ca_system_score_gemma":0.001713329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001993826,"about_ca_topic_score_gemma":0.0001416674,"domain_scores_codex":[0.996626,0.0002815703,0.002044637,0.0002800835,0.0004640479,0.0003037132],"domain_scores_gemma":[0.9959696,0.0004541924,0.002003255,0.0002809772,0.0006378226,0.0006541765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02719654,0.03481926,0.6162243,0.00005083079,0.001208151,0.001041507,0.0007480626,0.000003564989,0.0001021165,0.000006594635,0.0008164064,0.3177827],"study_design_scores_gemma":[0.04013359,0.1198889,0.8221676,0.0001122238,0.002125333,0.00008874585,0.0003695982,0.0001512884,0.002296019,0.0001037735,0.01238432,0.0001785497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952046,0.0009027242,0.00005620852,0.0002309348,0.0007046111,0.0004872651,0.00008707567,0.00001293765,0.002313646],"genre_scores_gemma":[0.9950457,0.000198007,0.003577547,0.0004197816,0.0005539416,0.00001857793,0.00001805987,0.00001617992,0.0001521666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3176041,"threshold_uncertainty_score":0.8040383,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1306409340776007,"score_gpt":0.4902485044401154,"score_spread":0.3596075703625146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}